June 2026: FDA Delays Approval of Achieve’s Cytisinicline Over Manufacturing Issues The U.S. Food and Drug Administration (FDA) has declined to approve Achieve Life Sciences's smoking cessation drug cytisinicline, issuing a Complete Response Letter that cites unresolved issues at a third-party manufacturing facility and incomplete product labeling. Importantly, the agency...